Dapagliflozin to Prevent Anthracycline-Induced Cardiotoxicity

NCT06888505 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Anthracyclines-Induced Cardiotoxicity
Cardiotoxicity

Interventions

DRUG: Dapagliflozin (Forxiga)
OTHER: Placebo

Sponsor

Hawler Medical University

Collaborators

[object Object]